Crow Point Partners cut its position in Novartis AG by 39.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,224 shares of the company's stock after selling 781 shares during the period.



from Biotech News http://ift.tt/1UfHDkV by